Trademark: 79306116
Word
FEZOBRAVA
Status
Registered
Status Code
700
Status Date
Tuesday, January 18, 2022
Serial Number
79306116
Registration Number
6617308
Registration Date
Tuesday, January 18, 2022
Mark Type
4000
Filing Date
Thursday, December 10, 2020
Published for Opposition
Tuesday, November 2, 2021

Trademark Owner History

Classifications
5 Pharmaceutical preparations, products and substances for the treatment and management of vasomotor symptoms and symptoms and conditions associated with menopause, all relating to women's health

Trademark Events
Sep 9, 2023
Change Of Name/Address Rec'd From Ib
Jul 18, 2022
Final Decision Transaction Processed By Ib
Jun 29, 2022
Final Disposition Notice Sent To Ib
Jun 28, 2022
Final Disposition Processed
Apr 18, 2022
Final Disposition Notice Created, To Be Sent To Ib
Mar 30, 2022
Teas Change Of Correspondence Received
Mar 30, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 30, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 18, 2022
Correction From Ib Entered - No Review Required
Jan 18, 2022
Registered-Principal Register
Dec 18, 2021
Correction Transaction Received From Ib
Nov 27, 2021
New Representative At Ib Received
Nov 6, 2021
Change Of Name/Address Rec'd From Ib
Nov 2, 2021
Official Gazette Publication Confirmation E-Mailed
Nov 2, 2021
Published For Opposition
Oct 13, 2021
Notification Of Notice Of Publication E-Mailed
Sep 24, 2021
Approved For Pub - Principal Register
Sep 23, 2021
Teas/Email Correspondence Entered
Sep 22, 2021
Correspondence Received In Law Office
Sep 22, 2021
Teas Response To Office Action Received
Jun 28, 2021
Refusal Processed By Ib
Jun 9, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Jun 9, 2021
Refusal Processed By Mpu
Jun 5, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Jun 4, 2021
Non-Final Action Written
Jun 2, 2021
Assigned To Examiner
Mar 16, 2021
Application Filing Receipt Mailed
Mar 12, 2021
New Application Office Supplied Data Entered
Mar 11, 2021
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24